For an owner considering the sale of a healthcare business, one of the first questions is usually: What is my business worth?

It is an important question, but determining value involves much more than applying a multiple to last year’s earnings. Two healthcare businesses with similar revenue and profits can receive very different offers. The difference may reflect the quality and predictability of their earnings, growth prospects, customer or referral concentration, management depth, regulatory risk, or how dependent the business remains on its owner.

When a prospective buyer makes an offer, the discussion often begins with EBITDA and a valuation multiple. A business owner may be told that the company is worth seven or eight times EBITDA. That sounds straightforward. But before deciding whether an offer is attractive, the seller needs to understand two things: what EBITDA figure the buyer is using and what the proposed purchase price will ultimately mean in dollars received and obligations retained.

Published on:
Updated:

Hiring a Private Caregiver in New Jersey: Understanding the Legal, Financial and Safety Risks

As more individuals choose to remain in their homes as they age, families are increasingly faced with an important decision: hire a private caregiver directly or obtain personal care services through a registered New Jersey Health Care Service Firm.

The difference involves much more than cost.

Published on:
Updated:

For a business owner who has never dealt with private equity, the first call with a PE firm can feel more significant than it usually is. In most cases, it is not a negotiation and it is certainly not a due diligence exercise. The first call is typically an exploratory conversation, generally lasting 30 minutes to an hour and usually conducted virtually. That does not mean it is unimportant. The first call often determines whether there will be a second one.

During the first call the PE firm is trying to decide whether your company fits its investment strategy and whether the owner is someone it wants to spend more time with. The owner should approach the conversation in much the same way. This is an opportunity to learn who is on the other side of the table and whether further discussions make sense.

Understand the Purpose of the Call

Published on:
Updated:

The eye care sector has become one of the most active areas in healthcare M&A, driven by an aging demographic, the rise of the medical optometry, and significant private equity interest. For practice owners and buyers alike, this presents substantial opportunity, along with complex legal pitfalls that can derail a transaction.

Buying or selling an optometry or ophthalmology practice is fundamentally different from purchasing a typical small business. These transactions sit at the intersection of corporate law, healthcare regulation, and professional licensure rules. A deal that looks clean on the financials can collapse during diligence when regulatory or structural issues surface.

The Corporate Practice Doctrine

Private equity has become the dominant force reshaping healthcare ownership in the United States. Investors are actively pursuing physician practices, ambulatory surgery centers, behavioral health organizations, home health and hospice agencies, dental and dermatology groups, physical therapy providers, infusion companies, and med spas. Capital is abundant. Attractive targets are not.

The healthcare organizations that command premium valuations share a common trait: they prepared long before entering the market. Purchase price and valuation multiples dominate the conversation, but sophisticated buyers evaluate management depth, financial integrity, compliance infrastructure, and growth trajectory. These factors, more than trailing earnings, determine what a practice’s worth.

What Private Equity Buyers Are Really Buying

In Health Care, Structure Drives Outcome

In health care transactions, purchase price is only part of the story. Deal structure is where acquisitions succeed or fail.

Health care acquisitions are not like other business transactions. Buyers are not simply acquiring furniture, equipment, and accounts receivable. They are acquiring a business built on reimbursement systems, regulatory compliance, payer relationships, provider productivity, and clinical operations. If the transaction is not structured carefully, the buyer can inherit problems they never intended to assume.

During the COVID-19 pandemic, New Jersey Governor Phil Murphy issued an executive order which, among other things, temporarily suspended and waived the requirement that Advanced Practice Nurses (“APNs”) enter into a joint protocol agreement with a collaborating physician in order to prescribe medications and devices. The waiver was intended to allow APNs to practice with expanded autonomy to meet urgent health care demands during the pandemic. Prior to the end of his final term, Governor Murphy issued Executive Order 415, terminating many pandemic emergency declarations and associated waivers, including the waiver of the joint protocol requirement which was set to expire on February 16, 2026. In response, current Governor Mikie Sherrill issued Executive Order 13, extending the COVID-era waiver of joint protocol agreements for 45 days and acknowledging pending legislation, Senate Bill 2996.

Key Changes for APNs

New Jersey Senate Bill 2996 was introduced into the legislature on January 13, 2026 proposing to permanently eliminate practice restrictions that limited APNs’ ability to prescribe and administer medications and devices. In its initial form, Senate Bill 2996 authorized APNs who have completed 24 months or 2,400 hours of licensed, active, advanced nursing to practice without a joint protocol agreement. However, the bill that passed and was eventually signed into law by Governor Mikie Sherrill on March 30, 2026 is significantly different than the version initially proposed.

Lindabury attorney Stephen A. Timoni of the firm’s Health Care industry team was recently interviewed by Relias Media and offered tips and best practices for providers offering telehealth services.

Some of the topics covered in the article include:

  • privacy concerns due to the nontraditional electronic transmission of sensitive information among providers and patients

Stephen Timoni was recently interviewed by Karen Appold of Managed Healthcare Executive regarding significant changes on the horizon which are expected to affect both health insurers and providers alike.  Many are the result of a shift toward value-based care, a move toward decreased care in hospital settings, technological advances, and other forces.

Along these lines, Timoni says that consolidation has been motivated by the evolving and challenging commercial and government reimbursement models which include lower fee-for-service payment rates, value-based payment components, and incentives to move care from inpatient to outpatient settings. “Basic economic theory suggests that consolidation of hospitals and physicians enables these combined providers to charge higher prices to private payers as the result of a lack of competition,” Timoni says. “Likewise, combined insurers are able to charge higher premiums to their subscribers.”

You can read the full article online here.

“Owning real estate can be a great recruiting tool, and can lure physicians into a larger practice,” says Stephen Timoni in a recent interview with Healthcare Finance News’ Jeff Lagasse.

“They become a partner in the practice, but they also offer them a buy-in into the building,” he said. “That’s very interesting for a young physician because, down the road, what physician groups may be doing is they’ll sell their building for a gain to a real estate investment trust or hospital system, and then they’ll lease the building back from the hospital. So they cash in on their equity.”

Another option for physician groups is to retain the real estate and lease it back to the health system for additional income — providing better overall economics, largely in the form of tax benefits.

Contact Information